# User-requested exploratory interpretation — 2026-09-19

During the fixed four-seed replication, the user clarified that useful variation
among correct routes and success on unseen challenges matter more to their toy
creativity hypothesis than strict absence of a route signature from training.
This is an explicitly retrospective change of interpretive emphasis, not a
change to training, cohorts, seed list, the primary endpoint, or frozen controls.
All four T1 paired results remain reported; strict U_novel/K is supplementary.

Use only existing retained outputs, with no further inference beyond the already
accepted ABC and three-point temperature controls:

- Within-model productive route variation: U_valid/K (distinct valid raw routes
  per 32 draws), valid-solution coverage, duplicate/concentration measures where
  already retained. Report 1k/2k/4k/8k trajectories and full-validation strata as
  well as the 80/20 mixture. Invalid or repeated routes do not count as additional
  productive diversity. Finite-K diversity also depends on route quality.
- Transfer: each fresh pair's sampled and greedy success on frozen unseen-map C,
  and mixed-composition full-validation challenge success. These are distinct
  generalization settings; neither is a released final test. A/B remain context.
- Quality comparability: retain the exact previously frozen temperature grid and
  matching criteria. If unmatched, clearly label diversity differences as
  quality-confounded/descriptive, not a demonstrated same-quality advantage.
- Between-model policy disagreement and valid-route overlap describe different
  behavior, not within-model diversity. Entropy can reflect valid ambiguity or
  error; interpret it alongside q-relative proper scores and exact route validity.

The final synthesis answers whether this toy evidence supports useful varied
solutions and unseen-challenge success, not broad human creativity. Preserve the
fresh-four primary paired estimate, discovery separation and small-n uncertainty.
Aggregation is read-only reporting over reviewed artifacts; no new helper or
scientific endpoint is represented as preregistered.
